Early Allograft Dysfunction: Causes, Recognition, and Management
Early Allograft Dysfunction: Causes, Recognition, and Management
复制标题
DOI:
10.1002/lt.23746
复制
发表时间:
2013-11-01
影响因子:
4.6
通讯作者:
Deschenes, Marc
中科院分区:
文献类型:
--
作者:
Deschenes, Marc
1. Early allograft dysfunction (EAD) defines grafts with marginal function early after liver transplantation. It has been validated in the Model for End-Stage Liver Disease era. 2. EAD is an important cause of morbidity and mortality after liver transplantation. 3. Both donor and recipient risk factors are associated with the development of EAD. 4. The use of statistical models has helped to predict EAD for given donor-recipient matches. 5. The identification of cytokine profiles associated with EAD may help to define potential interventions in the future.As we try to offer grafts to as many candidates as possible on our liver transplant waiting list, we are called to expand our organ donor pool. One problem is the variability in early graft function. Although a mild postoperative rise in aminotransferases during the first 48 to 72 hours is a relatively benign event, primary graft nonfunction requires emergency retransplantation. Marginal function of the newly implanted graft also represents an adverse event. Although the nomenclature for defining such poorly functioning grafts in the early posttransplant period is not well standardized, it is accepted that they are an important cause of morbidity and mortality for recipients.